What is Cephalexin used for

Cephalexin-ratiopharm 500 mg film-coated tablets

Patient information for Cephalexin-ratiopharm 500 mg film-coated tablets

1. What Cephalexin-ratiopharm 500 mg film-coated tablets is and what it is used for

1.1 What are the properties of the medicinal product?

1.1.a) Cephalexin-ratiopharm 500 mg film-coated tablets contains as a medicinally active ingredient

- Cefalexin.

This active ingredient belongs to the following active ingredient group (s):

- 1st generation cephalosporins

- Other beta-lactam antibiotics

- antibiotics for systemic use.

1.1.b) Submission status

Cephalexin-ratiopharm 500 mg film-coated tablets requires a prescription and may only be taken on medical advice.

1.2 What is the strength and dosage form?

Cephalexin-ratiopharm 500 mg film-coated tablets contains film-coated tablets with

- Cefalexin (H2O) 500,000 mg.

Your doctor will determine whether this strength and dosage form are suitable for your treatment.

1.3 Cephalexin-ratiopharm 500 mg film-coated tablets is used

The areas of application of the drug are usually derived from the association with the active ingredient groups that are specified in Chapter 1.1 (Properties).

Please note that no list of special areas of application is given here. Therefore, please read the package insert or ask your doctor or pharmacist if you have any questions.

2. Before you take Cephalexin-ratiopharm 500 mg film-coated tablets

Cephalexin-ratiopharm 500 mg film-coated tablets must not be used in case of hypersensitivity (allergy) to any active substance or any of the other ingredients of Cephalexin-ratiopharm 500 mg film-coated tablets.

Medicines can be subject to further contraindications, restrictions of use and interactions; please note that it is not a complete list of contraindications, restrictions on use and interactions. Therefore, please read the package insert or ask your doctor or pharmacist if you are not sure whether this medicine is suitable for you. In particular with children, elderly patients, pregnant or breastfeeding women as well as patients with diseases of the heart, circulatory system, kidneys, liver or blood sugar disease, clarity should be given in this regard before use.

3. How should Cephalexin-ratiopharm 500 mg film-coated tablets be taken?

Always use Cephalexin-ratiopharm 500 mg film-coated tablets exactly as your doctor has told you. Please read the package insert or ask your doctor or pharmacist if you are not entirely sure about the type and duration of use and the dosage.

4. What are the possible side effects?

Please note that no list of all side effects is given here. Therefore, please read the package insert or ask your doctor or pharmacist if you have any questions.

If you notice any undesirable side effects while taking this medicine, do not just stop taking the medicine, but contact your doctor or pharmacist.

If you have an acute side effect and severe symptoms develop, inform a doctor immediately, as certain drug side effects (e.g. excessive drop in blood pressure, hypersensitivity reactions) can under certain circumstances have serious consequences. In such cases, do not continue to take the medicine without doctor's advice.

5. How to store Cephalexin-ratiopharm 500 mg film-coated tablets

Store Cephalexin-ratiopharm 500 mg film-coated tablets at normal room temperature and store the medicinal product in the original packaging, protected from light and moisture, unless the manufacturer provides otherwise and, for example, recommends storage in the refrigerator. If necessary, please read the package insert or ask your pharmacist if you have any questions.

Medicines should generally be kept out of the reach of children.

Do not use the medicine after the expiry date stated on the pack.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer need. This measure helps to protect the environment.

6. Source and processing status

Information from the SCHOLZ database (R)

Copyright by ePrax GmbH, Munich; April 2011